EUVIMEDObjevte EUVIMED
Crossref

The antihypertensive agent ACT ‐132577 alleviates cuproptosis and pressure‐overload‐induced vascular remodelling by modulation of the NEDD4‐LCTR1‐copper signaling

Rui Qiang Qi, Yu Fei Chen, Xiao-Yan Yang, Zhao Jie Dong, Lin Zhao, Wei-Ming Li, Jing Cheng, Qi Wang, Jing Li, Jiu-Chang Zhong iD

The FEBS Journal · 2026

DOI: 10.1111/febs.70341 ↗

At a glance

Journal article in The FEBS Journal, 2026. Written by Rui Qiang Qi and 9 co-authors. Institution: Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital and Beijing Institute of Respiratory Medicine, Capital Medical Uni…. Major MEDLINE topics: Vascular Remodeling, Copper, Antihypertensive Agents, Nedd4 Ubiquitin Protein Ligases. Cited 4 times so far (Crossref); 45 references. Funded by: National Health Commission of China, National Major Science and Technology Projects, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

ACT‐132577 is a newly approved anti‐hypertensive agent in the treatment of hypertension and related cardiovascular diseases. However, its exact roles and underlying mechanisms beyond simple blood pressure regulation remain largely unclear. This study aims to elucidate the role of ACT‐132577 in CTR1–copper–cuproptosis signalling and vascular injury. Twelve‐week‐old spontaneously hypertensive rats (SHRs) and eight‐week‐old C57BL/6J mice undergoing abdominal aortic constriction (AAC) and primary vascular smooth muscle cells (VSMCs) were used to investigate the effects of ACT‐132577 on vascular remodelling. Administration of ACT‐132577 effectively reduced copper levels and Copper Transporter 1 (CTR1) protein expression in aortic tissues. These changes were linked to alleviation of cuproptosis, evidenced by increased levels of Ferredoxin1, lipoylated‐Dihydrolipoamide S‐Acetyltransferase (lipo‐DLAT) and lipo‐Dihydrolipoamide S‐Succinyltransferase (lipo‐DLST), as well as lower levels of DLAT oligomer and heat shock protein 70. Additionally, both ACT‐132577 and tetrathiomolybdate treatment strikingly mitigated vascular remodelling in SHRs, with decreases in medial thickness, vascular diameter and the cross‐sectional area of blood vessels. In vitro experiments corroborated these findings, revealing that ACT‐132577 suppressed platelet‐derived growth factor subunit beta‐induced VSMC phenotypic transition, which was evidenced by reduced cellular migration, maintained cell contractility, upregulated contractile markers (SM22a, Acta2, Myh11) and downregulated secretory markers (MMP2, MMP9, OPN). Mechanistically, ACT‐132577 upregulated E3 ubiquitin‐protein ligase NEDD4‐like (NEDD4L), thus promoting K48 ubiquitination of CTR1. More importantly, knocking down NEDD4L significantly abolished the effects of ACT‐132577 on cuproptosis and VSMC phenotypic transition. In conclusion, ACT‐132577 plays a crucial role in cuproptosis and aortic remodelling by modulation of the NEDD4L–CTR1–copper signaling, providing a novel perspective on its therapeutic potential in mitigating pressure overload‐induced vascular remodelling.

Subjects

MeSH terms (MEDLINE)

Vascular RemodelingCopperAntihypertensive AgentsNedd4 Ubiquitin Protein LigasesCopper Transporter 1HypertensionAnimalsMiceRatsSignal TransductionMaleRats, Inbred SHRMuscle, Smooth, VascularMice, Inbred C57BLMyocytes, Smooth Muscle

Author keywords

ACT‐132577copper transporter 1cuproptosisvascular remodellingvascular smooth muscle cells

Substances

CopperAntihypertensive AgentsNedd4 Ubiquitin Protein LigasesCopper Transporter 1

Authors and institutions

  • Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital and Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, China.
  • Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

ORCID profiles: Jiu-Chang Zhong

Funding

  • National Health Commission of China, National Major Science and Technology Projects
  • National Natural Science Foundation of China

Cite

APA

Qi, R. Q., Chen, Y. F., Yang, X. Y., Dong, Z. J., Zhao, L., Li, W. M., Cheng, J., Wang, Q., Li, J., & Zhong, J. C. (2026). The antihypertensive agent ACT ‐132577 alleviates cuproptosis and pressure‐overload‐induced vascular remodelling by modulation of the NEDD4‐LCTR1‐copper signaling. The FEBS Journal. https://doi.org/10.1111/febs.70341

Vancouver

Qi RQ, Chen YF, Yang XY, Dong ZJ, Zhao L, Li WM, et al. The antihypertensive agent ACT ‐132577 alleviates cuproptosis and pressure‐overload‐induced vascular remodelling by modulation of the NEDD4‐LCTR1‐copper signaling. The FEBS Journal. 2026. doi:10.1111/febs.70341

BibTeX
@article{Qi2026,
  author = {Qi, Rui Qiang and Chen, Yu Fei and Yang, Xiao-Yan and Dong, Zhao Jie and Zhao, Lin and Li, Wei-Ming and Cheng, Jing and Wang, Qi and Li, Jing and Zhong, Jiu-Chang},
  title = {The antihypertensive agent ACT ‐132577 alleviates cuproptosis and pressure‐overload‐induced vascular remodelling by modulation of the NEDD4‐LCTR1‐copper signaling},
  journal = {The FEBS Journal},
  year = {2026},
  doi = {10.1111/febs.70341}
}
Start for free →